Renal cortical thickness and PON1 activity both decrease in chronic renal failure

Journal of Nephrology

Volumn 15, Issue 2, 2002, Pages 144-149

  Ak, Gülçin ^a   Özgönül, Mert ^a   Sözmen, Eser Y ^a   Aslan, S Leyla ^a   Sözmen, Bülent ^a  

^a Department of Internal Medicine ^*  (Turkey)

Author keywords

Chronic renal failure; ox LDL; Paraoxonase

Indexed keywords

ARYLDIALKYLPHOSPHATASE; CATALASE; COPPER; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; ESTERASE; PON1 PROTEIN, HUMAN;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE MARKER; DISEASE PREDISPOSITION; ECHOGRAPHY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; HEMODIALYSIS; HUMAN; IN VITRO STUDY; KIDNEY CORTEX; KIDNEY SIZE; LIPID BLOOD LEVEL; LIPID COMPOSITION; LIPID OXIDATION; MALE; OXIDATIVE STRESS; PHENOTYPE; PROTECTION; THICKNESS; BLOOD; ENZYMOLOGY; METABOLISM; MIDDLE AGED; RENAL REPLACEMENT THERAPY;

ADULT; DISEASE PROGRESSION; ESTERASES; FEMALE; HUMAN; KIDNEY FAILURE, CHRONIC; LIPOPROTEINS, HDL CHOLESTEROL; LIPOPROTEINS, LDL; MALE; MIDDLE AGE; OXIDATIVE STRESS; RENAL DIALYSIS; THIOBARBITURIC ACID REACTIVE SUBSTANCES; ARYLDIALKYLPHOSPHATASE; CHOLESTEROL, HDL; HUMANS; MIDDLE AGED;

EID: 0035988238     PISSN: 11218428     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Lipid abnormalities in chronic renal insufficiency
2. Serum paraoxonase activity is decreased in uremic patients
3. Antioxidant enzymes and trace elements in hemodialyzed patients
4. Oxidized low density lipoprotein: Atherogenic and proinflammatory characteristics during macrophage foam cell formation. An inhibitory role for nutritional antioxidants and serum paraoxonase
5. A variant of human paraoxonase/arylesterase (HUMPONA) gene is a risk factor for coronary artery disease
6. Does paraoxonase play a role in susceptibility to cardiovascular disease?
7. Enhanced LDL oxidation in uremic patients: An additional mechanism for accelerated atherosclerosis?
8. Oxidation of low density lipoprotein in patients on regular hemodialysis
9. Oxidation of low density lipoproteins from patients with renal failure or renal transplants
10. The human serum paraoxonase/arylesterase polymorphism
11. Molecular basis for the polymorphic forms of human serum paraoxonase/arylesterase; Glutamine or arginine at position 191, for respective A or B allozymes
12. Susceptibility to in vitro lipid peroxidation of low density lipoproteins and erythrocyte membranes from liver cirrhotic patients
13. Protein measurement with folin phenol reagent
14. Microsomal lipid peroxidation
15. Accelerated atherosclerosis in prolonged maintenance hemodialysis
16. Atherosclerosis - An inflammatory disease
17. Alpha-tocopherol supplementation decreases the oxidative susceptibility of LDL in renal failure patients on dialysis therapy
18. Increased susceptibility of LDL to in vitro oxidation in patients on maintenance hemodialysis; Effects of fish oil and vitamin E administration
19. Oxidation of low density lipoprotein in hemodialysis patients: Effect of dialysis and comparison with matched controls
20. HDL composition and HDL antioxidant capacity in patients on regular hemodialysis
21. Serum paraoxonase and platelet-activating factor acetyl hydrolase in chronic renal failure
22. The serum paraoxonase activity in patients with chronic renal failure and hyperlipidemia
23. Oxidized LDL, glomerular mesangial cells and collagen
24. Effects of low density lipoprotein on type IV collagen production by cultured rat mesangial cells
25. Atherogenesis and cardiac death: Are they related to dialysis procedure and biocompatibility?